HOWL

Werewolf Therapeutics, Inc. HOWL

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$3.91M total
RA CAPITAL MANAGEMENT, L.P.
$859.3K-64.3%
BALYASNY ASSET MANAGEMENT L.P.
$644.3KNew
VANGUARD CAPITAL MANAGEMENT LLC
$438.5K0.0%
RENAISSANCE TECHNOLOGIES LLC
$242.8K+30.7%
Lynx1 Capital Management LP
$236.7K0.0%
SPHERA FUNDS MANAGEMENT LTD.
$225.6K0.0%
DC Funds, LP
$212.0K0.0%
Verdad Advisers, LP
$125.5K+1071.7%
GEODE CAPITAL MANAGEMENT, LLC
$120.9K-13.8%
BANK OF AMERICA CORP /DE/
$111.8K+17.7%
XTX Topco Ltd
$97.7K+433.1%
JANE STREET GROUP, LLC
$90.6K+204.0%
UBS Group AG
$77.7K+222.8%
VANGUARD FIDUCIARY TRUST CO
$56.8K0.0%
STATE STREET CORP
$42.9K0.0%
Squarepoint Ops LLC
$37.2KNew
BlackRock, Inc.
$36.6K0.0%
Rangeley Capital, LLC
$36.0KNew
NORTHERN TRUST CORP
$31.3K0.0%
Alyeska Investment Group, L.P.
$31.2K0.0%
MPM BioImpact LLC
$28.9K-93.4%
MILLENNIUM MANAGEMENT LLC
$22.3K-53.0%
Virtu Financial LLC
$16.0KNew
GSA CAPITAL PARTNERS LLP
$10.0KNew
TWO SIGMA INVESTMENTS, LP
$9.8KNew
See all 45 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/HOWL

Earnings Per Share

13fpro.ai/company/HOWL

Loading ratio trend…

HOWL insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Werewolf Therapeutics, Inc. (HOWL): stock profile, AI score and financials

Werewolf Therapeutics, Inc. (HOWL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. HOWL is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of HOWL by reported 13-F value include RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P., VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HOWL trades on the Nasdaq exchange and files with the SEC under CIK 1785530. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HOWL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Werewolf Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1785530 →